- Home
- DERM vs BSL Comparison
DERM vs BSL Comparison
Compare DERM & BSL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DERM
- BSL
- Stock Information
- Founded
- DERM 2014
- BSL 2010
- Country
- DERM United States
- BSL United States
- Employees
- DERM N/A
- BSL N/A
- Industry
- DERM Biotechnology: Pharmaceutical Preparations
- BSL Trusts Except Educational Religious and Charitable
- Sector
- DERM Health Care
- BSL Finance
- Exchange
- DERM Nasdaq
- BSL Nasdaq
- Market Cap
- DERM 190.7M
- BSL 185.1M
- IPO Year
- DERM 2021
- BSL N/A
- Fundamental
- Price
- DERM $7.94
- BSL $13.87
- Analyst Decision
- DERM Strong Buy
- BSL
- Analyst Count
- DERM 3
- BSL 0
- Target Price
- DERM $12.67
- BSL N/A
- AVG Volume (30 Days)
- DERM 153.4K
- BSL 71.9K
- Earning Date
- DERM 11-07-2025
- BSL 01-01-0001
- Dividend Yield
- DERM N/A
- BSL 9.55%
- EPS Growth
- DERM N/A
- BSL N/A
- EPS
- DERM N/A
- BSL N/A
- Revenue
- DERM $56,397,000.00
- BSL N/A
- Revenue This Year
- DERM $26.16
- BSL N/A
- Revenue Next Year
- DERM $45.27
- BSL N/A
- P/E Ratio
- DERM N/A
- BSL N/A
- Revenue Growth
- DERM N/A
- BSL N/A
- 52 Week Low
- DERM $3.54
- BSL $12.19
- 52 Week High
- DERM $8.90
- BSL $14.56
- Technical
- Relative Strength Index (RSI)
- DERM 66.43
- BSL 40.11
- Support Level
- DERM $7.38
- BSL $13.75
- Resistance Level
- DERM $8.20
- BSL $13.91
- Average True Range (ATR)
- DERM 0.36
- BSL 0.11
- MACD
- DERM 0.09
- BSL 0.01
- Stochastic Oscillator
- DERM 93.80
- BSL 48.19
About DERM Journey Medical Corporation
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.
About BSL Blackstone
Blackstone Senior Floating Rate Term Fund is a diversified, closed-end management investment company. Its primary investment objective is to seek high current income, with a secondary objective to seek preservation of capital, consistent with its primary goal of high current income. It also invests in second-lien loans and high yield bonds and employs financial leverage which may increase the risk to the Fund.